Myeong Lee - EyeGene Assistant Managing Director
| 185490 Stock | KRW 2,790 190.00 0.53% |
Managing Director
Myeong Lee is Assistant Managing Director of EyeGene
| Age | 45 |
| Phone | 82 2 322 1687 |
| Web | http://www.eyegene.co.kr |
EyeGene Management Efficiency
The company has return on total asset (ROA) of (0.19) % which means that it has lost $0.19 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (51.1998) %, meaning that it generated substantial loss on money invested by shareholders. EyeGene's management efficiency ratios could be used to measure how well EyeGene manages its routine affairs as well as how well it operates its assets and liabilities.EyeGene has accumulated 676.06 M in total debt with debt to equity ratio (D/E) of 1.6, which is about average as compared to similar companies. EyeGene has a current ratio of 4.81, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist EyeGene until it has trouble settling it off, either with new capital or with free cash flow. So, EyeGene's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EyeGene sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EyeGene to invest in growth at high rates of return. When we think about EyeGene's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 7 records | MANAGING DIRECTOR Age | ||
| Chang Kim | Stic Investments | N/A | |
| TaeJun Eom | SV Investment | N/A | |
| Hugh Shin | Stic Investments | N/A | |
| SungQue Koh | Stic Investments | N/A | |
| De Park | Stic Investments | N/A | |
| Min Sung | Stic Investments | N/A | |
| TakKun Oh | SV Investment | N/A | |
Management Performance
| Return On Equity | -51.2 | |||
| Return On Asset | -0.19 |
EyeGene Leadership Team
Elected by the shareholders, the EyeGene's board of directors comprises two types of representatives: EyeGene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EyeGene. The board's role is to monitor EyeGene's management team and ensure that shareholders' interests are well served. EyeGene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EyeGene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Song Kim, Assistant Managing Director | ||
| Jin Jang, Assistant Managing Director | ||
| Myeong Lee, Assistant Managing Director | ||
| WonIl Yoo, Chief Pres | ||
| YangJe Cho, CoFounder Officer | ||
| Won Yoo, President, Chief Executive Officer, Director | ||
| Du Kim, Director | ||
| Soobeom Lee, Chief Officer | ||
| Jong Choi, Internal Auditor | ||
| Wan Cho, Director |
EyeGene Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EyeGene a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -51.2 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (3.95) % | |||
| Current Valuation | 576.45 B | |||
| Shares Outstanding | 10.99 M | |||
| Shares Owned By Insiders | 9.70 % | |||
| Shares Owned By Institutions | 0.30 % | |||
| Price To Sales | 66.02 X | |||
| Revenue | 3.24 B | |||
| Gross Profit | 1.54 B |
Pair Trading with EyeGene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EyeGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EyeGene will appreciate offsetting losses from the drop in the long position's value.Moving against EyeGene Stock
| 0.65 | 105560 | KB Financial Group | PairCorr |
| 0.5 | 047810 | Korea Aerospace Indu | PairCorr |
| 0.41 | 003530 | Hanwha InvestmentSecuri | PairCorr |
| 0.38 | 086790 | Hana Financial | PairCorr |
The ability to find closely correlated positions to EyeGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EyeGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EyeGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EyeGene to buy it.
The correlation of EyeGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EyeGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EyeGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EyeGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in EyeGene Stock
EyeGene financial ratios help investors to determine whether EyeGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EyeGene with respect to the benefits of owning EyeGene security.